Losartan Potassium
Product Images NDC 50090-5338

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 01)

Chemical structure of Losartan Potassium, showing its molecular arrangement including aromatic rings, a tetrazole group, and potassium ion (K+).*

FDA Label Image

Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)

A line graph comparing the percentage of patients with a primary endpoint over a study period of 66 months between Atenolol and Losartan potassium. The y-axis represents the percentage of patients, and the x-axis shows study months. The graph indicates an adjusted risk reduction of 13% for Losartan potassium with a p-value of 0.021.*

FDA Label Image

Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period between Atenolol and Losartan potassium treatments. The graph shows lower stroke incidence for Losartan potassium with an adjusted risk reduction of 25%, p=0.001.*

FDA Label Image

Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)

A forest plot chart comparing the event rates and hazard ratios of Losartan Potassium versus Atenolol for primary composite outcomes and stroke (fatal/non-fatal) across different patient subgroups, including age, gender, race, ISH status, diabetes, and history of cardiovascular disease. The plot visually represents hazard ratios with confidence intervals, indicating whether results favor Losartan Potassium or Atenolol.*

FDA Label Image

Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)

A line graph comparing the percentage of patients with an event over 48 months between Losartan potassium and placebo groups. The graph includes a risk reduction of 16.1% with a p-value of 0.022, with Losartan potassium represented by a solid line and placebo by a dotted line.*

FDA Label Image

Label Image (Lbl500905338)

Label for LOSARTAN POTASSIUM 100 mg tablets from A-S Medication Solutions. The label states each tablet contains Losartan Potassium 100 mg and includes storage instructions to keep at 77 degrees Fahrenheit and protect from light. It specifies the package contains 90 film-coated tablets and has the NDC 50090-5338-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.